Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 23 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-11 Levine Mitchell S CFO Grant or award +10,121 46,700
2020-09-12 Levine Mitchell S CFO Purchase +10,000 $2.01 $20K 13,495
2020-08-03 Parker Albert P Chief Operating Officer Purchase +5,000 $1.33 $7K 5,000
2020-08-03 KALAJIAN TONY T Sr.VP/Chief Accounting Officer Purchase +5,000 $1.31 $7K 15,000
2020-08-03 ANDREWS RONALD ASBURY Chief Executive Officer Purchase +40,000 $1.35 $54K 102,698
2020-08-03 Levine Mitchell S Chief Financial Officer Purchase +10,000 $1.32 $13K 36,579
2020-06-17 Redmond Cavan M. Director Grant or award · Option to purchase common stock +62,000 62,000
2020-06-17 GRIFFITH MELINDA Director Grant or award · Option to purchase common stock +57,000 57,000
2020-06-17 Last Andrew J. Director Grant or award · Option to purchase common stock +57,000 57,000
2020-06-17 KINGSLEY ALFRED D Director Grant or award · Option to purchase common stock +57,000 57,000
2020-06-17 Arno Andrew Director Grant or award · Option to purchase common stock +57,000 57,000
2020-05-07 ANDREWS RONALD ASBURY Chief Executive Officer Grant or award · Restricted Stock Units +106,221 106,221
2020-04-28 Levine Mitchell S Chief Financial Officer Grant or award · Restricted Stock Units +20,000 20,000
2020-04-28 Levine Mitchell S Chief Financial Officer Grant or award · Restricted Stock Units −20,000 20,000
2020-04-24 BROADWOOD PARTNERS, L.P. 10% owner Purchase +1,050,000 $2.27 $2.4M 14,716,204
2020-04-24 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 14,716,204
2020-03-31 ANDREWS RONALD ASBURY CEO and President Purchase +18,000 $2.37 $43K 62,698
2020-03-31 ANDREWS RONALD ASBURY CEO and President Purchase +18,000 $2,372.00 $42.7M 62,698
2020-03-30 ANDREWS RONALD ASBURY CEO and President Purchase +27,216 $2.26 $61K 44,698
2020-03-30 ANDREWS RONALD ASBURY CEO and President Purchase +27,216 $2.26 $61K 44,698

Page 16 of 20 · 383 trades